CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-21 | SAMAD SAM Executive Vice President & CFO | Grant or award | +90 | $235.94 | $21K | 33,568 |
| 2026-07-22 | SAMAD SAM Executive Vice President & CFO | Grant or award | +102 | $206.81 | $21K | 33,478 |
| 2026-04-20 | SAMAD SAM Executive Vice President & CFO | Grant or award | +108 | $194.70 | $21K | 33,376 |
| 2026-03-04 | SAMAD SAM Executive Vice President & CFO | Grant or award | +13,947 | $204.86 | $2.9M | 40,988 |
| 2026-03-04 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −7,720 | $204.86 | $1.6M | 33,268 |
| 2026-03-02 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −869 | $204.86 | $178K | 27,041 |
| 2026-02-18 | SAMAD SAM Executive Vice President & CFO | Grant or award | +3,965 | 29,706 | ||
| 2026-02-18 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −855 | $210.01 | $180K | 28,851 |
| 2026-02-18 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −1,010 | $206.99 | $209K | 27,841 |
| 2026-02-18 | SAMAD SAM Executive Vice President & CFO | Grant or award · Non-Qualifed Stock Option (right to buy) | +18,303 | 18,303 | ||
| 2026-01-28 | SAMAD SAM Executive Vice President & CFO | Grant or award | +69 | $183.51 | $13K | 27,910 |
| 2025-10-21 | SAMAD SAM Executive Vice President & CFO | Grant or award | +68 | $189.08 | $13K | 25,741 |
| 2025-07-21 | SAMAD SAM Executive Vice President & CFO | Other acquisition | +72 | $167.50 | $12K | 25,673 |
| 2025-07-16 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −850 | $169.01 | $144K | 25,601 |
| 2025-04-21 | SAMAD SAM Executive Vice President & CFO | Other acquisition | +74 | $164.42 | $12K | 26,451 |
| 2025-03-04 | SAMAD SAM Executive Vice President & CFO | Grant or award | +13,884 | $173.74 | $2.4M | 34,061 |
| 2025-03-04 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −7,684 | $173.74 | $1.3M | 26,377 |
| 2025-02-26 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −869 | $171.75 | $149K | 20,177 |
| 2025-02-19 | SAMAD SAM Executive Vice President & CFO | Shares withheld for taxes | −1,031 | $169.71 | $175K | 21,046 |
| 2025-02-12 | SAMAD SAM Executive Vice President & CFO | Grant or award | +4,538 | 22,077 |
Page 1 of 2 · 34 trades